Usefulness of high-concentration calcium chloride solution for correction of activated partial thromboplastin time (APTT) in patients with high-hematocrit value

Thrombosis Research

Volumn 121, Issue 6, 2008, Pages 781-785

  Kanahara, Masaaki ^a   Kai, Hisashi ^b   Okamura, Takashi ^c   Wada, Toyofumi ^c   Suda, Kenji ^c   Imaizumi, Tsutomu ^b   Sagawa, Kimitaka ^a  

^a KURUME UNIVERSITY HOSPITAL   (Japan)

^b Cardiovascular Research Institute   (Japan)

^c KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

APTT; Calcium chloride solution; CLSI method; Pseudohigh APTT values

Indexed keywords

CALCIUM CHLORIDE; CALCIUM ION; CITRIC ACID;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL LABORATORY; CONGENITAL HEART DISEASE; FEMALE; HEMATOCRIT; HUMAN; MALE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL;

ADULT; ANTICOAGULANTS; BLOOD COAGULATION; BLOOD COAGULATION TESTS; CALCIUM CHLORIDE; CITRATES; CYANOSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART DEFECTS, CONGENITAL; HEMATOCRIT; HUMANS; MALE; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SOLUTIONS;

EID: 41849106147     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2007.08.004     Document Type: Article

References (7)

1. Spector I. Control of heparin therapy with activated partial thromboplastin times. JAMA 201 (1967) 75-77
2. Zucker S., and Cathev M.H. Control of heparin. Sensitivity of the activated partial thromboplastin time for the monitoring the antithrombotic effects of heparin. J Lab Clin Med 73 (1969) 320-326
3. Anand S.S., Yusuf S., Pogue J., Ginsberg J.S., and Hirsh J. Relationship of activated partial thromboplastin time to coronary events and bleeding in patients with acute coronary syndromes who receive heparin. Circulation 107 (2003) 2884-2888
4. Crowell E.B., Clatanoff D.V., and Kiekhofer W. The effect of oral contraceptive on factor VIII levels. J Lab Clin Med 77 (1971) 551-557
5. Solomon G.E., Hilgartner M.W., and Kutt H. Coagulation defects caused by diphenylhydantoin. Neurology 22 (1972) 1165-1171
6. Hattersley P.G., and Havse D.l. The effect of increased contact activation time on the activated partial thromboplastin time. Am J Clin Pathol 66 (1976) 479-482
7. National Committee for Clinical Laboratory Standards: Transport and Processing of Blood Specimens for Coagulation. Testing and General Performance of Coagulation assay, Approved Guideline. NCCLS Document. Third edition (1998) H21-A3, P1-23